259 related articles for article (PubMed ID: 11274584)
1. Hyperhemolytic transfusion reaction in sickle cell disease.
Win N; Doughty H; Telfer P; Wild BJ; Pearson TC
Transfusion; 2001 Mar; 41(3):323-8. PubMed ID: 11274584
[TBL] [Abstract][Full Text] [Related]
2. Prevention of potential delayed hemolytic transfusion reaction in two sickle cell patients using intravenous immunoglobulins and steroids before and after red blood cell exchange with antigen positive units and review literature.
Shold J; Dasgupta A; Ye Z
Transfus Apher Sci; 2024 Jun; 63(3):103920. PubMed ID: 38570214
[TBL] [Abstract][Full Text] [Related]
3. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
Win N; Sinha S; Lee E; Mills W
Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
[TBL] [Abstract][Full Text] [Related]
4. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review.
Win N; New H; Lee E; de la Fuente J
Transfusion; 2008 Jun; 48(6):1231-8. PubMed ID: 18373500
[TBL] [Abstract][Full Text] [Related]
5. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.
Cullis JO; Win N; Dudley JM; Kaye T
Vox Sang; 1995; 69(4):355-7. PubMed ID: 8751307
[TBL] [Abstract][Full Text] [Related]
6. Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report.
Win N; Lee E; Needs M; Chia LW; Stasi R
Transfus Med; 2012 Apr; 22(2):137-41. PubMed ID: 22233101
[TBL] [Abstract][Full Text] [Related]
7. The sickle cell hemolytic transfusion reaction syndrome.
Petz LD; Calhoun L; Shulman IA; Johnson C; Herron RM
Transfusion; 1997 Apr; 37(4):382-92. PubMed ID: 9111275
[TBL] [Abstract][Full Text] [Related]
8. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review.
Vasanthamohan L; Choo S; Marshall T; Symons YT; Matsui D; Eastabrook G; Solh Z
Transfusion; 2020 Oct; 60(10):2448-2455. PubMed ID: 32851670
[TBL] [Abstract][Full Text] [Related]
9. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
10. Delayed hemolytic transfusion reaction in children with sickle cell disease.
de Montalembert M; Dumont MD; Heilbronner C; Brousse V; Charrara O; Pellegrino B; Piguet C; Soussan V; Noizat-Pirenne F
Haematologica; 2011 Jun; 96(6):801-7. PubMed ID: 21330322
[TBL] [Abstract][Full Text] [Related]
11. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.
King KE; Shirey RS; Lankiewicz MW; Young-Ramsaran J; Ness PM
Transfusion; 1997 Apr; 37(4):376-81. PubMed ID: 9111274
[TBL] [Abstract][Full Text] [Related]
12. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease.
Reyes MA; Illoh OC
Immunohematology; 2008; 24(2):45-51. PubMed ID: 19852130
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease.
Shaulov A; Rund D; Filon D; Nachmias B; Khalili A; Manny N; Zelig O
Transfusion; 2023 May; 63(5):1100-1106. PubMed ID: 36866433
[TBL] [Abstract][Full Text] [Related]
14. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
Blauel ER; Grossmann LT; Vissa M; Miller ST
J Pediatr Hematol Oncol; 2015 Oct; 37(7):e438-40. PubMed ID: 26207780
[TBL] [Abstract][Full Text] [Related]
15. Anti-N and anti-Do
Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
[TBL] [Abstract][Full Text] [Related]
16. Hyperhemolysis in sickle cell disease.
Aragona E; Kelly MJ
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e54-6. PubMed ID: 23619113
[TBL] [Abstract][Full Text] [Related]
17. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease.
Win N; Yeghen T; Needs M; Chen FE; Okpala I
Hematology; 2004; 9(5-6):433-6. PubMed ID: 15763986
[TBL] [Abstract][Full Text] [Related]
18. Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
Lee LE; Beeler BW; Graham BC; Cap AP; Win N; Chen F
Transfusion; 2020 Jan; 60(1):30-35. PubMed ID: 31642065
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
Fasano RM; Miller MJ; Chonat S; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
[TBL] [Abstract][Full Text] [Related]
20. A delayed hemolytic transfusion reaction after partial exchange transfusion for sickle cell disease in pregnancy: a case report and review of the literature.
Brumfield CG; Huddleston JF; DuBois LB; Harris BA
Obstet Gynecol; 1984 Mar; 63(3 Suppl):13S-15S. PubMed ID: 6700873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
